Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: Involvement in p53 regulation and cisplatin resistance

British Journal of Cancer

Volumn 98, Issue 11, 2008, Pages 1803-1809

  Leung, E L ^a,b,c   Fraser, M ^a,b,d   Fiscus, R R ^c,e   Tsang, B K ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e NEVADA CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Cisplatin; Nitric oxide; NOS; Ovarian cancer; p53

Indexed keywords

ARGININE; CISPLATIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N ACETYL S NITROSOPENICILLAMINE; N AMINO LEVO ARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING; S-NITROSO-N-ACETYLPENICILLAMINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 44349175448     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604375     Document Type: Article

References (27)

1. Ambs S, Hussain SP, Harris CC (1997) Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 11: 443-448
2. Bellamy TC, Griffiths C, Garthwaite J (2002) Differential sensitivity of guanylyl cyclase and mitochondrial respiration to nitric oxide measured using clamped concentrations. J Biol Chem 277: 31801-31807
3. Chan SL, Fiscus RR (2003) Guanylyl cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) inhibitor KT5823 trigger apoptotic DNA fragmentation in immortalized uterine epithelial cells: anti-apoptotic effects of basal cGMP/PKG. Mol Hum Reprod 9: 775-783
4. Cheng Chew SB, Leung PY, Fiscus RR (2003) Preincubation with atrial natriuretic peptide protects NG108-15 cells against the toxic/proapoptotic effects of the nitric oxide donor S-nitroso-N-acetylpenicillamine. Histochem Cell Biol 120: 163-171
5. Fiscus RR (2002) Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals 11: 175-190
6. Fiscus RR, Tu AW, Chew SB (2001) Natriuretic peptides inhibit apoptosis and prolong the survival of serum-deprived PC12 cells. Neuroreport 12: 185-189
7. Fiscus RR, Yuen JP, Chan SL, Kwong JH, Chew SB (2002) Nitric oxide and cyclic GMP as pro- and anti-apoptotic agents. J Card Surg 17: 336-339
8. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC, Felley-Bosco E, Wang XW, Geller DA, Tzeng E, Billiar TR, Harris CC (1996) Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci USA 93: 2442-2447
9. Forstermann U, Gath I, Schwarz P, Closs EI, Kleinert H (1995) Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol 50: 1321-1332
10. Fraser M, Bai T, Tsang BK (2008) Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function. Int J Cancer 122: 534-546
11. Fraser M, Chan SL, Chan SS, Fiscus RR, Tsang BK (2006) Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells. Oncogene 25: 2203-2212
12. Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK (2003a) Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reprod Biol Endocrinol 1: 66
13. Fraser M, Leung BM, Yan X, Dan HC, Cheng JQ, Tsang BK (2003b) p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. Cancer Res 63: 7081-7088
14. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS (1994) Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79: 1137-1146
15. Mannick JB, Miao XQ, Stamler JS (1997) Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem 272: 24125-24128
16. Reif DW, McCreedy SA (1995) N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Arch Biochem Biophys 320: 170-176
17. Rieder J, Jahnke R, Schloesser M, Seibel M, Czechowski M, Marth C, Hoffmann G (2001) Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines. Gynecol Oncol 82: 172-176
18. Sasaki H, Sheng Y, Kotsuji F, Tsang BK (2000) Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 60: 5659-5666
19. Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279
20. Son KK, Hall KJ (2000) Nitric oxide-mediated tumor cell killing of cisplatin-based interferon-gamma gene therapy in murine ovarian carcinoma. Cancer Gene Ther 7: 1324-1328
21. Tang CH, Grimm EA (2004) Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines. J Biol Chem 279: 288-298
22. Tejedo JR, Ramirez R, Cahuana GM, Rincon P, Sobrino F, Bedoya FJ (2001) Evidence for involvement of c-Src in the anti-apoptotic action of nitric oxide in serum-deprived RINm5F cells. Cell Signal 13: 809-817
23. Thomsen LL, Miles DW (1998) Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 17: 107-118
24. Thomsen LL, Scott JM, Topley P, Knowles RG, Keerie AJ, Frend AJ (1997) Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res 57: 3300-3304
25. Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB (1993) Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 90: 9813-9817
26. Wink DA, Vodovotz Y, Cook JA, Krishna MC, Kim S, Coffin D, DeGraff W, Deluca AM, Liebmann J, Mitchell JB (1998) The role of nitric oxide chemistry in cancer treatment. Biochemistry (Mosc) 63: 802-809
27. Yuan ZQ, Feldman RI, Sussman GE, Coppola D, Nicosia SV, Cheng JQ (2003) AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol Chem 278: 23432-23440